Expression of cellular adhesion proteins and abnormal glycoproteins in human aberrant crypt foci

Michael J. Wargovich, Phyllis Chang, Marco Velasco, Frank A Sinicrope, Edward Eisenbrodt, Joseph Sellin

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Aberrant crypt foci (ACFs) may be the earliest recognizable histologic precursor lesion for colon cancer. ACF may develop from a complex of events, including the development of cryptal hyperproliferation, defects in the rate of apoptosis, and abnormalities in cellular adhesion. In this study, we hypothesized that human ACF would exhibit discrete differences in cell adhesion proteins compared with normal mucosa of biologic markers associated with colon cancer. ACFs were isolated from resected colon mucosa from 45 patients undergoing surgery for colon cancer. We evaluated the protein expression of 3 biologic markers that may be related to the progression of aberrant crypt foci to tumors: carcinoembryonic antigen, E-cadherin, and sialyl Tn antigen. In general, ACFs located near cancers in the right colon were more often hyperplastic than dysplastic; this was more noticeable in the left colon. Carcinoembryonic antigen expression was found to be more intense in apical portions of ACF crypts, with sialyl Tn antigen moderately increased, whereas E-cadherin diffusely stained throughout crypts within ACFs. There are significant biologic changes in potential tumor markers that accompany the early transformation of the normal glandular epithelium, some of which are expressed very early in the colon at the stage of appearance of ACF.

Original languageEnglish (US)
Pages (from-to)350-355
Number of pages6
JournalApplied Immunohistochemistry and Molecular Morphology
Volume12
Issue number4
StatePublished - Dec 2004

Fingerprint

Aberrant Crypt Foci
Glycoproteins
Proteins
Colon
Colonic Neoplasms
Carcinoembryonic Antigen
Cadherins
Mucous Membrane
Biomarkers
Neoplasm Antigens
Tumor Biomarkers
Cell Adhesion
Epithelium
Apoptosis

Keywords

  • Aberrant crypt
  • Carcinoembryonic antigen
  • Cell adhesion
  • Colon
  • E-cadherin
  • Glycoprotein
  • Sialyl Tn antigen

ASJC Scopus subject areas

  • Anatomy
  • Medical Laboratory Technology

Cite this

Expression of cellular adhesion proteins and abnormal glycoproteins in human aberrant crypt foci. / Wargovich, Michael J.; Chang, Phyllis; Velasco, Marco; Sinicrope, Frank A; Eisenbrodt, Edward; Sellin, Joseph.

In: Applied Immunohistochemistry and Molecular Morphology, Vol. 12, No. 4, 12.2004, p. 350-355.

Research output: Contribution to journalArticle

Wargovich, Michael J. ; Chang, Phyllis ; Velasco, Marco ; Sinicrope, Frank A ; Eisenbrodt, Edward ; Sellin, Joseph. / Expression of cellular adhesion proteins and abnormal glycoproteins in human aberrant crypt foci. In: Applied Immunohistochemistry and Molecular Morphology. 2004 ; Vol. 12, No. 4. pp. 350-355.
@article{9f0f06a6d2134cc392506c8f6e80b5da,
title = "Expression of cellular adhesion proteins and abnormal glycoproteins in human aberrant crypt foci",
abstract = "Aberrant crypt foci (ACFs) may be the earliest recognizable histologic precursor lesion for colon cancer. ACF may develop from a complex of events, including the development of cryptal hyperproliferation, defects in the rate of apoptosis, and abnormalities in cellular adhesion. In this study, we hypothesized that human ACF would exhibit discrete differences in cell adhesion proteins compared with normal mucosa of biologic markers associated with colon cancer. ACFs were isolated from resected colon mucosa from 45 patients undergoing surgery for colon cancer. We evaluated the protein expression of 3 biologic markers that may be related to the progression of aberrant crypt foci to tumors: carcinoembryonic antigen, E-cadherin, and sialyl Tn antigen. In general, ACFs located near cancers in the right colon were more often hyperplastic than dysplastic; this was more noticeable in the left colon. Carcinoembryonic antigen expression was found to be more intense in apical portions of ACF crypts, with sialyl Tn antigen moderately increased, whereas E-cadherin diffusely stained throughout crypts within ACFs. There are significant biologic changes in potential tumor markers that accompany the early transformation of the normal glandular epithelium, some of which are expressed very early in the colon at the stage of appearance of ACF.",
keywords = "Aberrant crypt, Carcinoembryonic antigen, Cell adhesion, Colon, E-cadherin, Glycoprotein, Sialyl Tn antigen",
author = "Wargovich, {Michael J.} and Phyllis Chang and Marco Velasco and Sinicrope, {Frank A} and Edward Eisenbrodt and Joseph Sellin",
year = "2004",
month = "12",
language = "English (US)",
volume = "12",
pages = "350--355",
journal = "Applied Immunohistochemistry and Molecular Morphology",
issn = "1541-2016",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Expression of cellular adhesion proteins and abnormal glycoproteins in human aberrant crypt foci

AU - Wargovich, Michael J.

AU - Chang, Phyllis

AU - Velasco, Marco

AU - Sinicrope, Frank A

AU - Eisenbrodt, Edward

AU - Sellin, Joseph

PY - 2004/12

Y1 - 2004/12

N2 - Aberrant crypt foci (ACFs) may be the earliest recognizable histologic precursor lesion for colon cancer. ACF may develop from a complex of events, including the development of cryptal hyperproliferation, defects in the rate of apoptosis, and abnormalities in cellular adhesion. In this study, we hypothesized that human ACF would exhibit discrete differences in cell adhesion proteins compared with normal mucosa of biologic markers associated with colon cancer. ACFs were isolated from resected colon mucosa from 45 patients undergoing surgery for colon cancer. We evaluated the protein expression of 3 biologic markers that may be related to the progression of aberrant crypt foci to tumors: carcinoembryonic antigen, E-cadherin, and sialyl Tn antigen. In general, ACFs located near cancers in the right colon were more often hyperplastic than dysplastic; this was more noticeable in the left colon. Carcinoembryonic antigen expression was found to be more intense in apical portions of ACF crypts, with sialyl Tn antigen moderately increased, whereas E-cadherin diffusely stained throughout crypts within ACFs. There are significant biologic changes in potential tumor markers that accompany the early transformation of the normal glandular epithelium, some of which are expressed very early in the colon at the stage of appearance of ACF.

AB - Aberrant crypt foci (ACFs) may be the earliest recognizable histologic precursor lesion for colon cancer. ACF may develop from a complex of events, including the development of cryptal hyperproliferation, defects in the rate of apoptosis, and abnormalities in cellular adhesion. In this study, we hypothesized that human ACF would exhibit discrete differences in cell adhesion proteins compared with normal mucosa of biologic markers associated with colon cancer. ACFs were isolated from resected colon mucosa from 45 patients undergoing surgery for colon cancer. We evaluated the protein expression of 3 biologic markers that may be related to the progression of aberrant crypt foci to tumors: carcinoembryonic antigen, E-cadherin, and sialyl Tn antigen. In general, ACFs located near cancers in the right colon were more often hyperplastic than dysplastic; this was more noticeable in the left colon. Carcinoembryonic antigen expression was found to be more intense in apical portions of ACF crypts, with sialyl Tn antigen moderately increased, whereas E-cadherin diffusely stained throughout crypts within ACFs. There are significant biologic changes in potential tumor markers that accompany the early transformation of the normal glandular epithelium, some of which are expressed very early in the colon at the stage of appearance of ACF.

KW - Aberrant crypt

KW - Carcinoembryonic antigen

KW - Cell adhesion

KW - Colon

KW - E-cadherin

KW - Glycoprotein

KW - Sialyl Tn antigen

UR - http://www.scopus.com/inward/record.url?scp=10044296027&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10044296027&partnerID=8YFLogxK

M3 - Article

C2 - 15536336

AN - SCOPUS:10044296027

VL - 12

SP - 350

EP - 355

JO - Applied Immunohistochemistry and Molecular Morphology

JF - Applied Immunohistochemistry and Molecular Morphology

SN - 1541-2016

IS - 4

ER -